Endocrinology & Metabolic SupportHSA/FSA ~30% Pre-Tax Recovery

GLP-1 & Dual GIP/GLP-1 Receptor Agonists: Nutrient Depletions, Dosing Rules & HSA/FSA Guide

Semaglutide (Ozempic, Wegovy, Rybelsus)Tirzepatide (Mounjaro, Zepbound)Liraglutide (Victoza, Saxenda)Dulaglutide (Trulicity)

Caloric restriction and slowed gastric emptying from GLP-1 receptor agonism accelerate disproportionate loss of fat-free skeletal muscle mass (25–40% of weight lost without resistance + protein co-intervention), reduce micronutrient intake, and increase constipation and hypovolemic electrolyte shifts.

Dosing Separation & Pharmacist Safety Rule

Oral medications or capsules may show delayed absorption on GLP-1 therapy; maintain 64+ oz hydration daily with buffered electrolytes and pair protein/creatine with progressive resistance exercise 2–3x/week. Disclose all supplements to prescriber if persistent nausea or biliary symptoms arise.

Documented Nutrient Depletions & Support Needs

Lean Muscle Preservation (Creatine Monohydrate + HMB)Strong Clinical Consensus

Supports phosphocreatine ATP regeneration and slows proteolysis during negative energy balance alongside resistance training.

Soluble GI Motility Fiber & Digestive EnzymesStrong Clinical Consensus

Mitigates GLP-1 delayed gastric emptying, satiety bloating, and slow colonic transit.

Bone Density & Micronutrient Buffer (D3+K2, Electrolytes, B12)FDA / Guideline Monitored

Rapid weight reduction decreases mechanical skeletal loading and oral B-vitamin / mineral density.

Lab Targets to Review

  • CMP / eGFR (hydration & creatinine stability)
  • Serum 25(OH) Vitamin D (40–60 ng/mL)
  • Serum Vitamin B12 + Ferritin
  • DEXA Body Composition (Appendicular Lean Mass Index)
IRS § 213(d) Pathway: GLP-1 lean muscle, bone-sparing, and GI motility formulations pair with obesity/prediabetes/type 2 diabetes ICD-10-CM diagnoses (E66.x, R73.03, E11.x) for ~30% pre-tax HSA/FSA savings.

Matched Physical Formulations & Supplies (8)

Quality-verified formulations and home monitoring equipment aligned to GLP-1 (Ozempic / Mounjaro / Zepbound).

Frequently Asked Questions — GLP-1 (Ozempic / Mounjaro / Zepbound) & Supplementation

What nutrients or physical functions are impacted by GLP-1 (Ozempic / Mounjaro / Zepbound)?+

Caloric restriction and slowed gastric emptying from GLP-1 receptor agonism accelerate disproportionate loss of fat-free skeletal muscle mass (25–40% of weight lost without resistance + protein co-intervention), reduce micronutrient intake, and increase constipation and hypovolemic electrolyte shifts. Key replenishment or monitoring areas include Lean Muscle Preservation (Creatine Monohydrate + HMB) (Supports phosphocreatine ATP regeneration and slows proteolysis during negative energy balance alongside resistance training.); Soluble GI Motility Fiber & Digestive Enzymes (Mitigates GLP-1 delayed gastric emptying, satiety bloating, and slow colonic transit.); Bone Density & Micronutrient Buffer (D3+K2, Electrolytes, B12) (Rapid weight reduction decreases mechanical skeletal loading and oral B-vitamin / mineral density.)

What is the most important dosing separation or safety rule with GLP-1 (Ozempic / Mounjaro / Zepbound)?+

Oral medications or capsules may show delayed absorption on GLP-1 therapy; maintain 64+ oz hydration daily with buffered electrolytes and pair protein/creatine with progressive resistance exercise 2–3x/week. Disclose all supplements to prescriber if persistent nausea or biliary symptoms arise.

Which lab tests should I discuss with my prescriber while taking GLP-1 (Ozempic / Mounjaro / Zepbound)?+

Recommended monitoring targets to review with your physician or pharmacist include: CMP / eGFR (hydration & creatinine stability), Serum 25(OH) Vitamin D (40–60 ng/mL), Serum Vitamin B12 + Ferritin, DEXA Body Composition (Appendicular Lean Mass Index).

Are targeted supplements or recovery supplies for GLP-1 (Ozempic / Mounjaro / Zepbound) HSA and FSA eligible?+

GLP-1 lean muscle, bone-sparing, and GI motility formulations pair with obesity/prediabetes/type 2 diabetes ICD-10-CM diagnoses (E66.x, R73.03, E11.x) for ~30% pre-tax HSA/FSA savings. Eligible physical products save roughly 22% to 37% (~30% average) when purchased or reimbursed with pre-tax HSA/FSA dollars backed by IRS Section 213(d) documentation.

All 12 Prescription Medication Depletion Guides

Launch Dual-Mode Interactive Checker →